Debt · Raised $23.4M · Sep 3, 2026announcement ↗
Tensive
Backed by
HealthtechMilan, Italytensive.com ↗
What they do
Tensive is a Milan-based clinical-stage medical device company developing REGENERA™ and SOFTAG™ bioresorbable biopolymer scaffolds for breast reconstruction and tissue marking after lumpectomy. Its products are intended for breast cancer patients and the surgeons who treat them, with pivotal clinical testing underway and first approvals expected in early 2027.
Hiring outlook
The €23.4 million debt financing and approach to regulatory approval suggest potential hiring in clinical operations, regulatory affairs, quality, manufacturing, and medical affairs. As commercialization approaches, Tensive may also add market access, sales, and supply-chain roles.
Open roles
No open roles on their board right now.